Related Experiment Videos
Localization of cyclooxygenase-2 in human sporadic colorectal adenomas
K S Chapple1, E J Cartwright, G Hawcroft
1Molecular Medicine Unit, Department of Histopathology, University of Leeds, St. James's University Hospital, Leeds, United Kingdom.
Abstract:
A putative target for the anti-colorectal cancer action of nonsteroidal anti-inflammatory drugs is the inducible isoform of cyclooxygenase (COX), COX-2. COX-2 is expressed within intestinal adenomas in murine polyposis models, but expression has been poorly characterized in human colorectal neoplasms. Therefore, we investigated the localization of the COX-2 protein in human sporadic colorectal adenomas. Immunohistochemistry for COX-2 and CD68 (a tissue macrophage marker) was performed on formalin-fixed, paraffin-embedded (n = 52) and frozen, acetone-fixed (n = 6) sections of human sporadic colorectal adenomas. Forty of 52 (77%) formalin-fixed adenomas expressed immunoreactive COX-2. COX-2 was localized to superficial interstitial macrophages in 39 cases (75%) and to deep interstitial macrophages in 9 cases (17%). COX-2 staining of dysplastic epithelial cells was observed in 15 cases (29%). A logistic regression analysis identified the adenoma site (P = 0.012) and histological type (P = 0.001) as independent predictors of superficial macrophage COX-2 expression. There was no relationship between the number of macrophages within an adenoma and macrophage COX-2 expression. These results indicate that COX-2 is expressed predominantly by interstitial macrophages within human sporadic colorectal adenomas. If COX-2 does indeed play a role in the early stages of colorectal carcinogenesis in man, these data suggest COX-2-mediated paracrine signaling between the macrophages and epithelial cells within adenomas.
Insights
Cyclooxygenase-2 (COX-2) is mainly found in interstitial macrophages within human colorectal adenomas. This suggests COX-2 may mediate signaling between macrophages and epithelial cells in early colorectal cancer development.
Area of Science:
- Oncology
- Inflammation Research
- Gastroenterology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) target cyclooxygenase-2 (COX-2) for anti-colorectal cancer effects.
- COX-2 expression is known in murine models but poorly characterized in human colorectal neoplasms.
- Understanding COX-2 localization is crucial for its role in colorectal carcinogenesis.
Purpose of the Study:
- To investigate the protein localization of COX-2 in human sporadic colorectal adenomas.
- To determine if COX-2 is expressed in dysplastic epithelial cells or associated macrophages.
- To identify potential predictors of COX-2 expression in adenomas.
Main Methods:
- Immunohistochemistry was used to detect COX-2 and CD68 (macrophage marker) in human colorectal adenomas.
- Sections were analyzed from formalin-fixed, paraffin-embedded (n=52) and frozen (n=6) samples.
- Logistic regression analysis was performed to identify predictors of COX-2 expression.
Main Results:
- Immunoreactive COX-2 was detected in 77% of formalin-fixed adenomas.
- COX-2 was predominantly localized to superficial interstitial macrophages (75%) and also found in deep macrophages (17%).
- COX-2 staining was observed in dysplastic epithelial cells in 29% of cases; adenoma site and histology predicted superficial macrophage COX-2 expression.
Conclusions:
- COX-2 is primarily expressed by interstitial macrophages in human sporadic colorectal adenomas.
- These findings suggest a potential role for COX-2-mediated paracrine signaling between macrophages and epithelial cells in early colorectal carcinogenesis.
- Further research is warranted to elucidate the precise mechanisms of COX-2 in colorectal cancer development.